ALT vs AMGN: Which Stock is Better?
Side-by-side comparison of Altimmune Inc and Amgen Inc in 2026
ALT
Altimmune Inc
$3.60
AMGN
Amgen Inc
$377.64
Key Metrics Comparison
| Metric | ALT | AMGN | Winner |
|---|---|---|---|
| Market Cap | $475.88M | $202.38B | AMGN |
| P/E Ratio | N/A | 26.38 | AMGN |
| EPS (TTM) | $N/A | $14.23 | AMGN |
| Revenue Growth | 4.2% | 0.1% | ALT |
| Gross Margin | -161929.3% | 70.8% | AMGN |
Analyze ALT
Full quant analysis
Analyze AMGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is ALT or AMGN a better investment?
Comparing ALT and AMGN: Altimmune Inc has a market cap of $475.88M while Amgen Inc has $202.38B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between ALT and AMGN?
ALT (Altimmune Inc) and AMGN (Amgen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: ALT or AMGN?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: ALT or AMGN?
ALT has higher revenue growth at 4.2% vs 0.1% for AMGN.
Which company is more profitable: ALT or AMGN?
Amgen Inc (AMGN) has higher gross margins at 70.8% compared to -161929.3% for ALT.
Which is the larger company: ALT or AMGN?
Amgen Inc (AMGN) is larger with a market cap of $202.38B compared to $475.88M for ALT.
Should I buy ALT or AMGN in 2026?
Both ALT and AMGN have investment merit. ALT trades at $3.60 while AMGN trades at $377.64. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between ALT and AMGN stock?
Key differences: Market Cap ($475.88M vs $202.38B), P/E Ratio (N/A vs 26.4x), Revenue Growth (4.2% vs 0.1%), Gross Margin (-161929.3% vs 70.8%).